The role of astrocytes in amyloid -protein toxicity and clearance
详细信息查看全文 | 推荐本文 |
摘要
The deposition of the amyloid -protein (A) in the brain is a pathological hallmark of Alzheimer's disease (AD). Here, A deposits occur as A plaques in the brain parenchyma and in the walls of cerebral and leptomenigeal blood vessels. Astrocytes are considered to be involved in the clearance of A from the brain parenchyma into the perivascular space, across the blood-brain barrier, or by enzymatic degradation. As such it has been assumed that clearance of A by astrocytes is beneficial. In a recent study published in Experimental Neurology Mulder et al. (2012; 233: 373-379) report changes in neprilysin and scavenger receptor class B member 1 gene expression in astrocytes exposed to fibrillar A depending on the availability of amyloid-associated proteins, especially apolipoprotein E (apoE). Astrocytes from AD patients did not show this response in gene expression. Reactive astrocytes and A containing astrocytes are common findings in the AD brain. A loss of excitatory amino acid transporter 2 expression in perivascular astrocytes of APOE 蔚4-positive AD cases and an alteration of neuronal apoE metabolism in the event of perivascular drainage of apoE-A complexes has also been described. As such, reactive and compensatory changes in AD astrocytes compete with supporting functions of astrocytes finally leading to an impairment of metabolic support and transmitter recycling in the brain. In summary, exposure of astrocytes to increased amounts of A over a long period in time very likely impairs the above mentioned supporting functions of astrocytes in AD patients because these cells have to clear large amounts of A and, thereby, neglect their other functions.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700